Related Experiment Video
Updated: Jun 28, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
A population-based cost-effectiveness analysis of olanzapine and risperidone among ambulatory patients with
Dan Cooper1, Jocelyne Moisan, Belkacem Abdous
1Faculty of Pharmacy, Université Laval, Québec, Canada.
Background:
Olanzapine and risperidone are atypical antipsychotics exhibiting different pharmacological properties that are likely to translate into differences in outcomes, tolerability and safety. As well, their acquisition cost differs. These differences may impact their cost-effectiveness.
Objective:
To estimate the incremental cost-effectiveness ratio (ICER) of olanzapine and risperidone in an outpatient population.
Methods:
We carried out a cost-effectiveness analysis based on resource utilization data gathered from Quebec's provincial health insurance board databases. Patients previously diagnosed with schizophrenia who received a first prescription of olanzapine or risperidone between 1 January 1997 and 31 August 1999 were followed for 365 days. Absence of hospitalization for mental illness served as the clinical indicator of effectiveness. Direct health care costs for mental illness were considered. Adjusted ICERs were calculated, and their 95% confidence intervals (CI) were assessed using a non-parametric bootstrap.
Results:
A total of 6,334 patients were included in the analysis. The ICER for olanzapine was (CA$) 86,918 (95%CI, 27,709 to 237,040) per additional effective treatment per year, among patients hospitalized prior to their treatment. Among those who were not hospitalized prior to their treatment, olanzapine was dominated (95%CI, CA$1.7M to dominated).
Conclusion:
Results suggest that, in this population, direct mental health care costs could be minimized by using risperidone instead of olanzapine as the initial treatment.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...